Neoplasm of cerebral hemisphere

disease
On this page

Also known as cerebral hemisphere neoplasmcerebral hemisphere tumorcerebral hemisphere tumourcerebral hemispheric neoplasmcerebral hemispheric tumorcerebral hemispheric tumourcerebral neoplasmcerebral neoplasmscerebral tumorcerebral tumourneoplasm of cerebral hemispheresneoplasm of cerebrumneoplasm of telencephalonneoplasm of the cerebral hemispheresneoplasm of the cerebrumtelencephalon neoplasm (disease)telencephalon tumortelencephalon tumourtumor of cerebral hemisphere

Summary

Neoplasm of cerebral hemisphere (MONDO:0021374) is a cancer (an umbrella term covering 7 Mondo subtypes) and 9 clinical trials. Top therapeutic interventions include gabapentin. A subtype of brain neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Umbrella term: 7 Mondo subtypes
  • Clinical trials: 9

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameneoplasm of cerebral hemisphere
Mondo IDMONDO:0021374
NCITC4874
SNOMED CT126953009
UMLSC1263885
MedGen224729
Anatomy (UBERON)UBERON:0001869
Is cancer (heuristic)yes

Also known as: cerebral hemisphere neoplasm · cerebral hemisphere tumor · cerebral hemisphere tumour · cerebral hemispheric neoplasm · cerebral hemispheric tumor · cerebral hemispheric tumour · cerebral neoplasm · cerebral neoplasms · cerebral tumor · cerebral tumour · neoplasm of cerebral hemisphere · neoplasm of cerebral hemispheres · neoplasm of cerebrum · neoplasm of telencephalon · neoplasm of the cerebral hemispheres · neoplasm of the cerebrum · telencephalon neoplasm (disease) · telencephalon tumor · telencephalon tumour · tumor of cerebral hemisphere (+11 more)

Disease family

This is a subtype of brain neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disordercentral nervous system disorderbrain disorderbrain neoplasmneoplasm of cerebral hemisphere

Related subtypes (16): brain cancer, cerebellopontine angle tumor, olfactory nerve neoplasm, cerebellar neoplasm, childhood brain meningioma, olfactory groove meningioma, dysembryoplastic neuroepithelial tumor, hypothalamic neoplasm, optic pathway glioma, choroid plexus neoplasm, brainstem neoplasm, pineal body neoplasm, benign neoplasm of brain, primary brain neoplasm, optic tract meningioma, infratentorial neoplasm

Subtypes (7): frontal lobe neoplasm, cerebral hemisphere cancer, occipital lobe neoplasm, neoplasm of temporal lobe, neoplasm of parietal lobe, benign neoplasm of cerebrum, cerebral astrocytoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 9.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified9

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05688683Not specifiedRECRUITINGBrain Representation of Acquisition in Humans of Motor-Sensory Skills
NCT07170436Not specifiedNOT_YET_RECRUITINGBrain Areas of Cognitive Functions: a Study in Awake Surgery
NCT07332234Not specifiedRECRUITINGOptic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies
NCT02306278Not specifiedCOMPLETEDThe Effects of Gabapentin Premedication on Neurosurgery
NCT02317055Not specifiedTERMINATEDMagnetic Resonance Imaging Evaluation of the Tissular Oxygen Saturation in Brain
NCT02491827Not specifiedTERMINATEDConfocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours
NCT03179176Not specifiedCOMPLETEDEvaluation of the Interest of Ultra-high Frequency Doppler Ultrasound (UFDU) in the Surgical Management of Patients Operated in an Awake Condition for a Cerebral Tumor
NCT04434651Not specifiedCOMPLETEDEffect of SPGB on ICP and Oxygenation of Cerebral Venous Outflow in Craniotomy for Cerebral Tumors.
NCT05103735Not specifiedCOMPLETEDPropofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
GABAPENTIN41